
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study”, Bmj, vol. 364, p. l525, 2019.
, “Association of practice size and pay-for-performance incentives with the quality of diabetes management in primary care”, Cmaj, vol. 183, pp. E809-16, 2011.
, “Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study”, Bmj, vol. 345, p. e5567, 2012.
, “Associations between attainment of incentivised primary care diabetes indicators and mortality in an English cohort”, Diabetes Res Clin Pract, vol. 174, p. 108746, 2021.
, “Bisphosphonates and risk of upper gastrointestinal cancer–a case control study using the General Practice Research Database (GPRD)”, PLoS One, vol. 7, p. e47616, 2012.
, ,
“Long-term trends in antithrombotic drug prescriptions among adults aged 80 years and over from primary care: a temporal trends analysis using electronic health records”, Ann Epidemiol, vol. 28, pp. 440-446, 2018.
, “Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease”, Diabetes Obes Metab, vol. 16, pp. 317-25, 2014.
, “Pay for perfomance and the quality of diabetes management in individuals with and without co-morbid medical conditions”, J R Soc Med, vol. 102, pp. 369-77, 2009.
, “Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing”, PLoS One, vol. 14, p. e0218115, 2019.
, ,
“Statin induced myopathy and myalgia: time trend analysis and comparison of risk associated with statin class from 1991-2006”, PLoS One, vol. 3, p. e2522, 2008.
, ,